GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bellicum Pharmaceuticals Inc (FRA:BPXA) » Definitions » Price-to-Tangible-Book

Bellicum Pharmaceuticals (FRA:BPXA) Price-to-Tangible-Book : (As of Jun. 20, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bellicum Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-06-20), Bellicum Pharmaceuticals's share price is €0.163. Bellicum Pharmaceuticals's Tangible Book per Share of Sep. 2023 for the quarter that ended in Sep. 2023 was €-2.67. Hence, Bellicum Pharmaceuticals's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Bellicum Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

During the past 11 years, Bellicum Pharmaceuticals's highest Price to Tangible Book Ratio was 42.34. The lowest was 0.51. And the median was 2.98.

FRA:BPXA's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.63
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Bellicum Pharmaceuticals's share price is €0.163. Bellicum Pharmaceuticals's Book Value per Sharefor the quarter that ended in Sep. 2023 was €-2.67. Hence, Bellicum Pharmaceuticals's P/B Ratio of today is .


Bellicum Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Bellicum Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bellicum Pharmaceuticals Price-to-Tangible-Book Chart

Bellicum Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.93 - - 0.52 2.71

Bellicum Pharmaceuticals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.27 2.71 - - -

Competitive Comparison of Bellicum Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, Bellicum Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bellicum Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bellicum Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Bellicum Pharmaceuticals's Price-to-Tangible-Book falls into.



Bellicum Pharmaceuticals Price-to-Tangible-Book Calculation

Bellicum Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2023 )
=0.163/-2.665
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Bellicum Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Bellicum Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Bellicum Pharmaceuticals (FRA:BPXA) Business Description

Traded in Other Exchanges
Address
3730 Kirby Drive, Suite 1200, Houston, TX, USA, 77098
Bellicum Pharmaceuticals Inc is a biopharmaceutical company that has discovered and developed novel, controllable cellular immunotherapies for various forms of cancer, including both hematological cancers and solid tumors. its proprietary Chemical Induction of Dimerization technology platform is designed to enable control of components of the immune system in real-time. Its product candidates are; BPX-601 an autologous GoCAR-T product candidate designed to treat solid tumors expressing prostate stem cell antigen, or PSCA, and BPX-603 an autologous dual-switch GoCAR-T product candidate designed to target solid tumors that express the human epidermal growth factor receptor 2 antigen, or HER2.

Bellicum Pharmaceuticals (FRA:BPXA) Headlines

No Headlines